A CASE OF IMMUNE CHECKPOINT INHIBITOR ASSOCIATED MYOCARDITIS IN NON-SMALL CELL LUNG CANCER

被引：0
|
作者：
Murphy, Andrew [1 ]
Ismail, Ali [1 ]
Monzer, Nasser [1 ]
Sangoi, Matthew [1 ]
Khan, Aarish Husain [1 ]
Khazan, Benjamin [1 ]
机构：
[1] Univ Penn Hlth Syst, Penn Hosp, Philadelphia, PA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1260-038
引用
收藏
页码：3191 / 3191
页数：1
相关论文
共 50 条
  • [41] Immuno-PET in predicting immune checkpoint inhibitor response in non-small cell lung cancer
    Silva, S. G.
    Amorim, D.
    Feijo, S.
    Barata, F. J.
    Figueiredo, A. M.
    Hrynchak, I.
    Silva, M.
    Moreira, A. P.
    Abrunhosa, A.
    Cordeiro, C.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S148 - S148
  • [42] The mechanism and risk factors for immune checkpoint inhibitor pneumonitis in non-small cell lung cancer patients
    Xiaoyang Zhai
    Jian Zhang
    Yaru Tian
    Ji Li
    Wang Jing
    Hongbo Guo
    Hui Zhu
    Cancer Biology & Medicine , 2020, (03) : 599 - 611
  • [43] Immune checkpoint inhibitor efficacy and safety in elderly non-small cell lung cancer patients.
    Watanabe, Hiromi
    Kubo, Toshio
    Ninomiya, Kiichiro
    Minami, Daisuke
    Kudo, Kenichiro
    Murakami, Etsuko
    Ochi, Nobuaki
    Ninomiya, Takashi
    Harada, Daijiro
    Yasugi, Masayuki
    Ichihara, Eiki
    Ohashi, Kadoaki
    Fujiwara, Keiichi
    Hotta, Katsuyuki
    Tabata, Masahiro
    Maeda, Yoshinobu
    Kiura, Katsuyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [44] Chemotherapy and immune checkpoint inhibitor combination, a new standard in squamous non-small cell lung cancer?
    Travert, Camille
    Tomasini, Pascale
    Barlesi, Fabrice
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (02) : 401 - 405
  • [45] Risk factors for immune checkpoint inhibitor-related pneumonitis in non-small cell lung cancer
    Chao, Yencheng
    Zhou, Jiebai
    Hsu, Shujung
    Ding, Ning
    Li, Jiamin
    Zhang, Yong
    Xu, Xiaobo
    Tang, Xinjun
    Wei, Tianchang
    Zhu, Zhengfei
    Chu, Qian
    Neal, Joel W.
    Wu, Julie Tsu-Yu
    Song, Yuanlin
    Hu, Jie
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 11 (02) : 295 - +
  • [46] The mechanism and risk factors for immune checkpoint inhibitor pneumonitis in non-small cell lung cancer patients
    Zhai, Xiaoyang
    Zhang, Jian
    Tian, Yaru
    Li, Ji
    Jing, Wang
    Guo, Hongbo
    Zhu, Hui
    CANCER BIOLOGY & MEDICINE, 2020, 17 (03) : 599 - 611
  • [47] Retrospective Efficacy Analysis of Immune Checkpoint Inhibitor Rechallenge in Patients with Non-Small Cell Lung Cancer
    Katayama, Yuki
    Shimamoto, Takayuki
    Yamada, Tadaaki
    Takeda, Takayuki
    Yamada, Takahiro
    Shiotsu, Shinsuke
    Chihara, Yusuke
    Hiranuma, Osamu
    Iwasaku, Masahiro
    Kaneko, Yoshiko
    Uchino, Junji
    Takayama, Koichi
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (01)
  • [48] EFFICACY OF SALVAGE CHEMOTHERAPY AFTER IMMUNE CHECKPOINT INHIBITOR IN NON-SMALL CELL LUNG CANCER PATIENTS
    Okamatsu, Yuki
    Inoue, Shigesato
    Utsumi, Takahiro
    Kayukawa, Takafumi
    Uryu, Kazuyasu
    Inoue, Katsuhiro
    Tsubouchi, Kazuya
    Harada, Taishi
    RESPIROLOGY, 2018, 23 : 286 - 286
  • [49] Immune checkpoint inhibitor-associated toxicity in advanced non-small cell lung cancer: An updated understanding of risk factors
    Hu, Xiangxiao
    Wang, Lina
    Shang, Bin
    Wang, Junren
    Sun, Jian
    Liang, Bin
    Su, Lili
    You, Wenjie
    Jiang, Shujuan
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [50] Immune Checkpoint Inhibitor Is Associated with Improved Survival in Advanced Non-small Cell Lung Cancer Occurring in Patients with Autoimmune Disease
    Ihara, Yasutaka
    Sawa, Kenji
    Imai, Takumi
    Nonomiya, Yuta
    Shimomura, Yuki
    Ishihara, Asahi
    Shintani, Ayumi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2024, 47 (02) : 454 - 461
12345